Gut hormones as potential new targets for appetite regulation and the treatment of obesity

被引：22

作者：

Field, Benjamin C. T. ^{[1
]}

Wren, Alison M. ^{[1
]}

Cooke, Dunstan ^{[2
]}

Bloom, Stephen R. ^{[1
,2
]}

机构：

[1] Hammersmith Hosp, Imperial Coll London, Dept Metab MEd, London W12 0NN, England

[2] Thiakis Ltd, Imperial Bioincubat, London, England

来源：

DRUGS | 2008年 / 68卷 / 02期

基金：

英国医学研究理事会;

关键词：

D O I：

10.2165/00003495-200868020-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Food intake and bodyweight are tightly regulated by the brainstem, hypothalamus and reward circuits. These centres integrate diverse cognitive inputs with humoral and neuronal signals of nutritional status. Our knowledge of the role of gut hormones in this complex homeostatic system has expanded enormously in recent years. This review discusses both the role of gut hormones in appetite regulation, and the current state of development of gut hormone-based obesity therapies, with a particular focus on pancreatic polypeptide, peptide YY, amylin, glucagon-like peptide-1, oxyntomodulin, cholecystokinin and ghrelin. Several gut hormone-based treatments for obesity are under investigation in phase II and III clinical trials, and many more are in the pipeline.

引用

页码：147 / 163

页数：17

共 247 条

[71] Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes [J].

DeFronzo, RA ;

Ratner, RE ;

Han, J ;

Kim, DD ;

Fineman, MS ;

Baron, AD .

DIABETES CARE, 2005, 28 (05) :1092-1100

[72] Effect of peptide YY3-36 on food intake in humans [J].

Degen, L ;

Oesch, S ;

Casanova, M ;

Graf, S ;

Ketterer, S ;

Drewe, J ;

Beglinger, C .

GASTROENTEROLOGY, 2005, 129 (05) :1430-1436

[73] High circulating ghrelin:: A potential cause for hyperphagia and obesity in Prader-Willi syndrome [J].

DelPparigi, A ;

Tschöp, M ;

Heiman, ML ;

Salbe, AD ;

Vozarova, B ;

Sell, SM ;

Bunt, JC ;

Tataranni, PA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12) :5461-5464

[74] Laparoscopic adjustable gastric banding induces prolonged satiety: A randomized blind crossover study [J].

Dixon, AFR ;

Dixon, JB ;

O'Brien, PE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :813-819

[75] Ghrelin increases food intake in obese as well as lean subjects [J].

Druce, MR ;

Wren, AM ;

Park, AJ ;

Milton, JE ;

Patterson, M ;

Frost, G ;

Ghatei, MA ;

Small, C ;

Bloom, SR .

INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (09) :1130-1136

[76]

DRUCE MR, 2007, THESIS IMPERIAL COLL

[77] OXYNTOMODULIN (GLUCAGON-37 OR BIOACTIVE ENTEROGLUCAGON) - A POTENT INHIBITOR OF PENTAGASTRIN-STIMULATED ACID-SECRETION IN RATS [J].

DUBRASQUET, M ;

BATAILLE, D ;

GESPACH, C .

BIOSCIENCE REPORTS, 1982, 2 (06) :391-395

[78] Cholecystokinin and gastrin receptors [J].

Dufresne, Marlene ;

Seva, Catherine ;

Fourmy, Daniel .

PHYSIOLOGICAL REVIEWS, 2006, 86 (03) :805-847

[79] A NEW MOLECULAR-FORM OF PYY - STRUCTURAL CHARACTERIZATION OF HUMAN PYY(3-36) AND PYY(1-36) [J].

EBERLEIN, GA ;

EYSSELEIN, VE ;

SCHAEFFER, M ;

LAYER, P ;

GRANDT, D ;

GOEBELL, H ;

NIEBEL, W ;

DAVIS, M ;

LEE, TD ;

SHIVELY, JE ;

REEVE, JR .

PEPTIDES, 1989, 10 (04) :797-803

[80] A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes [J].

Edelman, Steve ;

Garg, Satish ;

Frias, Juan ;

Maggs, David ;

Wang, Yan ;

Zhang, Bei ;

Strobel, Susan ;

Lutz, Karen ;

Kolterman, Orville .

DIABETES CARE, 2006, 29 (10) :2189-2195

← 3 4 5 6 7 8 9 10 11 12 →